期刊文献+

儿童感染肺炎链球菌的耐药性分析 被引量:2

下载PDF
导出
摘要 目的了解儿童肺炎链球菌(SP)的感染情况和对儿科常用抗菌药物的耐药状况,为预防感染和合理使用抗菌药物提供参考依据。方法采集患儿的临床标本进行肺炎链球菌的分离、鉴定和药敏试验,并统计分析其结果。结果共检出290株肺炎链球菌,未发现有耐万古霉素和阿莫西林/棒酸的肺炎球菌,对青霉素的MIC为0.003~1.0mg/L,未检出青霉素高耐药菌株,青霉素不敏感肺炎链球菌(PNSSP)达18.3%(53/290),对复方新诺明、克林霉素、红霉素、四环素、氯霉素、头孢呋辛、头孢克洛、氧氟沙星、头孢曲松的耐药率分别为:60.0%,59.3%,53.8%,41.4%,19.0%,16.2%,13.4%,3.1%,1.4%。结论肺炎链球菌是呼吸道感染和中耳炎的重要病原菌。应加强病原菌的耐药性监测,合理、谨慎使用抗菌药物,有效进行抗感染治疗,延缓耐药菌株的出现和遏制耐药株菌的播散。
出处 《中国实用医药》 2008年第30期86-87,共2页 China Practical Medicine
  • 相关文献

参考文献6

  • 1[1]Cochran J B,Panzarino V M,Maes L Y,et al.Pneumo-coccus induced T-antigen activation in hemolyticuremic syndrome and anemia.Pediatr Nephrol,2004,19:317-321.
  • 2[2]Hakenbeck R,Kaminski K,Konig A,et al.Penicillin binding proteins inβ-lactam streptococcus pneumoniae.Microb Drug Resist,1999,5:91-99.
  • 3[3]Sessegolo J F,Levin A S S,Levy C E,et al.Distribution of serotypes and antimicrobial resistance of streptococcus pneumon-iae srtains isolated in Brazil from 1998 to1992.J Clin Microbiol,1994,32:906-911.
  • 4杨永弘,陆权,邓力,沈叙庄,张泓,周宏,胡翼云,俞桑洁,张国成.四地儿童肺炎链球菌、流感嗜血杆菌抗生素敏感性监测(2000~2001年)[J].中华儿科杂志,2002,40(8):461-466. 被引量:96
  • 5陈彩平,张国成,杨永弘,沈叙庄,王咏红,李艳,许东亮,徐修礼,丁翠玲.西安地区呼吸道感染患儿肺炎链球菌携带和耐药情况分析[J].临床儿科杂志,2004,22(4):222-223. 被引量:12
  • 6[6]Hsu K K,Pelton S I.Heptavalent pneumococcal conjugate vac-cine:current and future impact.Expert Rev Vaccines,2003,2:619-631.

二级参考文献16

  • 1Di Guilmi AM, Dessen A. New approaches towards the identification of antibiotic and vaccine targets in Streptococcus pneumoniae. EMBO Rep, 2002, 3(8):728- 734.
  • 2Cochran JB, Panzarino VM, Maes LY, et al. Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia. Pediatr Nephrol, 2004, 19(3):317- 321.
  • 3Loeffler JM, Garbino J, Lew D, et al. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis, 2003, 35( 11 - 12): 843 - 850.
  • 4McCracken GH. Etiology and treatment of pneumonia.Pediatr Infect Dis J, 2000, 19(4): 373- 377.
  • 5Hortal M, Lovgren M, de la Hoz F, et al. Antibiotic resistance in Streptococcus pneumoniae in six Latin American countries: 1993- 1999 surveillance. Microb Drug Resist, 2001, 7(4) :391 - 401.
  • 6Evans ME. Determining the frequency of resistance of Streptococcus pneumoniae to ciprofloxacin,levofloxacin, trovafloxacin, grepafloxacin, and gemifloxacin. Eur J Clin Microbiol Infect Dis, 2001,20(12) :883- 885.
  • 7Jones RN.Microbiology of newer fluoroquinolones:focus on respiratory pathogens. Diagn Microbiol Infect Dis, 2002, 44(3) :213 - 220.
  • 8Chapman TM, Perry CM. Cefepime:a review of its use in the management of hospitalized patients with pneumonia. Am J Respir Med, 2003, 2(1): 75 - 107.
  • 9Hsu KK, Pelton SI. Heptavalent pneumococcal conjugate vaccine: current and future impact. Expert Rev Vaccines, 2003, 2(5): 619 - 631.
  • 10Asensi F, de Jose M, Lorente M, et al. A pharmacoeconomic evaluation of seven-valent pneumococcal conjugate vaccine in Spain. Value Health, 2004, 7(1):36- 51.

共引文献105

同被引文献12

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部